PHOTODYNAMICS/PEDIATRIC CARDIOLOGY: UV light-activated glue dramatically improves pediatric heart defect treatment

A new material with light-activated adhesive properties promises a dramatic improvement in treatment for children born with certain heart defects.1 The "glue" provides an on-demand, anti-bleeding seal within 5 s of ultraviolet light application, even when used on high-pressure large blood vessels and cardiac walls of a beating heart.

When a child is born with a defect such as a hole in the heart, the current treatment, a highly invasive therapy, is challenged by the difficulty of quickly and safely securing devices inside the heart. Sutures are time-intensive and can stress fragile heart tissue, and currently available clinical adhesives are either toxic or prone to failure in the presence of blood and dynamic conditions like heartbeats.

Waterproof, light-activated glue can successfully secure biodegradable patches to seal holes in a beating heart
Waterproof, light-activated glue can successfully secure biodegradable patches to seal holes in a beating heart. (Image courtesy of Karp Laboratory)

The innovation results from collaboration among researchers at Boston Children's Hospital, Brigham and Women's Hospital (BWH), and the Massachusetts Institute of Technology (MIT; all in Boston, MA). Inspired by the fact that many creatures secrete viscous, water-repellent substances that enable them to attach to wet surfaces in dynamic environments, the team designed the new material with these attributes and also to be biodegradable, elastic, and biocompatible. Their study demonstrated that degradable patches secured with the glue remained attached, even when the patient's heart rate and blood pressure increased.

The adhesive technology (and other related platforms) has been licensed to a start-up company, Gecko Biomedical (Paris, France). The company has raised $10.8 million (€8 million) in their recently announced Series A financing round and expects to bring the adhesive to the market within 2–3 years.

1. N. Lang et al., Sci. Transl. Med., 6, 218, 218ra6 (2014).

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS